Survey of Adrenal Insufficiency Management for Duchenne muscular dystrophy in Italy. [PDF]
Tornese G +6 more
europepmc +1 more source
(Z)-Endoxifen as a Potential Modulator of Utrophin Pathways in Duchenne Muscular Dystrophy: A Mechanistic and Transcriptomic Perspective. [PDF]
Remmel HL +3 more
europepmc +1 more source
Assessing movement quality in individuals with Duchenne muscular dystrophy utilizing accelerometry: Comparisons with healthy controls. [PDF]
Joy N +15 more
europepmc +1 more source
Cognitive deficits linked to intrinsic timescales and gray matter volume abnormalities in children with Duchenne muscular dystrophy. [PDF]
Niu X +17 more
europepmc +1 more source
FDA-approved antisense oligonucleotide therapies for duchenne muscular dystrophy: current status and future outlook. [PDF]
Moriyama H, Moriyama S, Yokota T.
europepmc +1 more source
Awareness of Duchenne muscular dystrophy among medical staff in China: a multicenter cross-sectional survey. [PDF]
Zhai C +8 more
europepmc +1 more source
Early Cardiac Manifestations as the Initial Presentation of Duchenne Muscular Dystrophy in Infancy. [PDF]
Shatarat F +3 more
europepmc +1 more source
Correction to: Task-based effective connectivity finds alterations in frontoparietal network in Duchenne muscular dystrophy. [PDF]
europepmc +1 more source
Vamorolone for Duchenne Muscular Dystrophy: A Cross-Trial Efficacy Comparison With Classic Corticosteroids From the FOR-DMD Trial. [PDF]
Clemens PR +11 more
europepmc +1 more source

